CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab.
Khan M, Ney DE, Kleinschmidt-DeMasters BK, Horton L, Alvarez E, Piquet AL. CNS atypical T-cell lymphoproliferative disease following treatment with alemtuzumab. Neurol Clin Pract. 2019 Jun; 9(3):273-276.